Iguana Healthcare Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$4.36M Hold
83,840
2.87% 7
2017
Q4
$4.5M Buy
83,840
+5,240
+7% +$290K 2.93% 10
2017
Q3
$4.8M Sell
78,600
-5,240
-6% -$318K 2.62% 11
2017
Q2
$5.13M Sell
83,840
-47,160
-36% -$2.87M 2.9% 8
2017
Q1
$7.94M Buy
131,000
+15,720
+14% +$954K 3.93% 6
2016
Q4
$6.48M Sell
115,280
-41,920
-27% -$2.45M 3.87% 7
2016
Q3
$9.36M Buy
157,200
+26,200
+20% +$1.53M 1.67% 21
2016
Q2
$7.2M Sell
131,000
-26,200
-17% -$1.39M 2.93% 7
2016
Q1
$7.94M Buy
157,200
+52,400
+50% +$2.57M 2.91% 9
2015
Q4
$5.28M Buy
+104,800
New +$5.28M 1.74% 14
2015
Q2
Sell
-52,400
Closed -$2.87M 80
2015
Q1
$2.87M Sell
52,400
-26,200
-33% -$1.48M 1.21% 30
2014
Q4
$4.26M Sell
78,600
-5,240
-6% -$292K 2.06% 15
2014
Q3
$4.74M Sell
83,840
-70,740
-46% -$3.97M 2.53% 10
2014
Q2
$8.53M Sell
154,580
-60,260
-28% -$3.29M 3.98% 7
2014
Q1
$11.6M Buy
214,840
+31,440
+17% +$1.63M 5.38% 4
2013
Q4
$8.76M Buy
+183,400
New +$8.38M 4.99% 3

Other funds holding MRK

Iguana Healthcare Management's MRK Position: Q1 2018 in Review

Iguana Healthcare Management held its Merck (MRK) position steady in Q1 2018 at 83,840 shares worth $4.36M. The position accounts for 2.87% of the portfolio, ranked #7.

Iguana Healthcare Management first reported a position in MRK in Q4 2013 and has held it in 16 quarters since. The position peaked at $11.6M in Q1 2014. 1,993 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • Iguana Healthcare Management held 83,840 shares of Merck worth $4.36M as of Q1 2018.
  • Iguana Healthcare Management left its Merck share count unchanged in Q1 2018.
  • Merck made up 2.87% of Iguana Healthcare Management's portfolio in Q1 2018, its #7 holding.
  • Iguana Healthcare Management first reported a position in Merck in Q4 2013 and has held it in 16 quarters since.
  • Iguana Healthcare Management's Merck position peaked at $11.6M in Q1 2014.
  • 1,993 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.